LivaNova (LIVN) Operating Income (QoQ) (2015 - 2026)
LivaNova (LIVN) Operating Income (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn |
| 10 | LivaNova | 4.39 Bn | 3.85 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60% |
| Dec 31, 2025 | -21.17% |
| Sep 30, 2025 | -0.32% |
| Jun 30, 2025 | 11.45% |
| Mar 31, 2025 | 31.32% |
| Dec 31, 2024 | 3.94% |
| Sep 30, 2024 | -11.32% |
| Jun 30, 2024 | 147.24% |
| Mar 31, 2024 | 118.46% |
| Dec 31, 2023 | -2,073.76% |
| Sep 30, 2023 | -74.34% |
| Jun 30, 2023 | 841.93% |
| Mar 31, 2023 | -116.78% |
| Dec 31, 2022 | 110.58% |
| Sep 30, 2022 | -515.58% |
| Jun 30, 2022 | 234.10% |
| Mar 31, 2022 | -61.60% |
| Dec 31, 2021 | 50.74% |
| Sep 30, 2021 | 145.29% |
| Jun 30, 2021 | -536.40% |